Jul. 30 at 5:37 PM
$CDXS The raise was a clean dilutive offering at a price discount, with no warrant tail. That is better financing than a registered direct with warrants. The 25% price discount is the entire cost. If CDXS trades back to
$3.00 on execution, the offering participants double their money and existing holders see full recovery — no warrant ceiling, no anti-dilution trigger, no overhang suppressing the rebound. Runway is extended or capital in place to fund a facility. Hopefully not an indication of deteriorating cash flow.
